Plexxikon Inc
General
Total Cases4
Active Cases3
Patents65
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
L2
B
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 11/07/22 | TRANSCRIPT ORDER for proceedings held on 7/12/2021 through 7/21/2021 (Trial) before Judge Haywood S Gilliam, Jr for Court Reporter Raynee Mercado. (oh, COURT STAFF) (Filed on 11/7/2022) (Entered: 11/07/2022) | |
| 11/07/22 | TRANSCRIPT ORDER for proceedings held on 7/12/2021 through 7/21/2021 (Trial) before Judge Haywood S Gilliam, Jr for Court Reporter Raynee Mercado. (oh, COURT STAFF) (Filed on 11/7/2022) (Entered: 11/07/2022) | |
| 11/02/22 | United States Court of Appeals for the Federal Circuit. Case Number 2023-1113 for 617 Notice of Appeal to the Federal Circuit filed by Novartis Pharmaceuticals Corporation. (jlg, COURT STAFF) (Filed on 11/2/2022) (Entered: 11/02/2022) | |
| 11/02/22 | United States Court of Appeals for the Federal Circuit. Case Number 2023-1113 for 617 Notice of Appeal to the Federal Circuit filed by Novartis Pharmaceuticals Corporation. (jlg, COURT STAFF) (Filed on 11/2/2022) (Entered: 11/02/2022) | |
| 10/27/22 | NOTICE OF APPEAL to the Federal Circuit by Novartis Pharmaceuticals Corporation. Filing fee $505, receipt number ACANDC-17671149. Case number: 2023-1113 Appeal Record due by 11/28/2022. (Zimmer, David) (Filed on 10/27/2022) Modified on 11/2/2022 (jlg, COURT STAFF). (Entered: 10/27/2022) | |
| 10/27/22 | NOTICE OF APPEAL to the Federal Circuit by Novartis Pharmaceuticals Corporation. Filing fee $505, receipt number ACANDC-17671149. Case number: 2023-1113 Appeal Record due by 11/28/2022. (Zimmer, David) (Filed on 10/27/2022) Modified on 11/2/2022 (jlg, COURT STAFF). (Entered: 10/27/2022) | |
| 10/20/22 | NOTICE of Appearance by David J Zimmer (Zimmer, David) (Filed on 10/20/2022) (Entered: 10/20/2022) | |
| 10/20/22 | NOTICE of Appearance by David J Zimmer (Zimmer, David) (Filed on 10/20/2022) (Entered: 10/20/2022) | |
| 10/13/22 | Costs Taxed in amount of $98,000.00 against Novartis Pharmaceuticals Corporation re 587 Bill of Costs. (kc, COURT STAFF) (Filed on 10/13/2022) (Entered: 10/13/2022) | |
| 10/13/22 | Costs Taxed in amount of $98,000.00 against Novartis Pharmaceuticals Corporation re 587 Bill of Costs. (kc, COURT STAFF) (Filed on 10/13/2022) (Entered: 10/13/2022) |